Collegium Pharmaceutical, Inc. (COLL)
27.39
+0.28
(+1.02%)
USD |
NASDAQ |
Aug 24, 16:00
27.39
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical 1 Year Total Returns (Daily) : -31.40% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | -31.40% |
| August 20, 2026 | -28.23% |
| August 19, 2026 | -23.62% |
| August 18, 2026 | -25.37% |
| August 17, 2026 | -25.62% |
| August 14, 2026 | -24.03% |
| August 13, 2026 | -25.65% |
| August 12, 2026 | -32.14% |
| August 11, 2026 | -28.11% |
| August 10, 2026 | -22.13% |
| August 07, 2026 | -10.53% |
| August 06, 2026 | -2.15% |
| August 05, 2026 | 14.92% |
| August 04, 2026 | 14.92% |
| August 03, 2026 | 18.32% |
| July 31, 2026 | 18.52% |
| July 30, 2026 | 17.20% |
| July 29, 2026 | 16.28% |
| July 28, 2026 | 14.48% |
| July 27, 2026 | 11.77% |
| July 24, 2026 | 9.62% |
| July 23, 2026 | 9.81% |
| July 22, 2026 | 9.73% |
| July 21, 2026 | 15.98% |
| July 20, 2026 | 13.91% |
| Date | Value |
|---|---|
| July 17, 2026 | 11.84% |
| July 16, 2026 | 14.16% |
| July 15, 2026 | 14.75% |
| July 14, 2026 | 6.67% |
| July 13, 2026 | 7.07% |
| July 10, 2026 | 6.76% |
| July 09, 2026 | 10.66% |
| July 08, 2026 | 13.49% |
| July 07, 2026 | 17.93% |
| July 06, 2026 | 23.46% |
| July 02, 2026 | 21.37% |
| July 01, 2026 | 18.38% |
| June 30, 2026 | 22.42% |
| June 29, 2026 | 20.21% |
| June 26, 2026 | 22.37% |
| June 25, 2026 | 16.95% |
| June 24, 2026 | 18.17% |
| June 23, 2026 | 15.86% |
| June 22, 2026 | 12.14% |
| June 18, 2026 | 13.31% |
| June 17, 2026 | 14.40% |
| June 16, 2026 | 16.63% |
| June 15, 2026 | 17.17% |
| June 12, 2026 | 17.03% |
| June 11, 2026 | 15.66% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Innoviva, Inc. | 5.51% |
| Zevra Therapeutics, Inc. | 24.82% |
| Supernus Pharmaceuticals, Inc. | 5.84% |
| Indivior Pharmaceuticals, Inc. | 53.31% |
| Crinetics Pharmaceuticals, Inc. | 188.1% |